The same analysis was thus performed on tumors from the Trp53+/+ cohort, which identified one tumor having a significant degree of Trp53flox recombination, which was excluded from the analysis of comparing Trp53+/+ versus Trp53-/- mice (Figure 2—figure supplement 1A). The gene discussed is TP53; the disease is neoplasm.